Category: Promising
-
6 Most Promising Crypto Projects in January 2025
•
With the beginning of the new year, the world of cryptocurrencies is full of new projects promising great returns. From funny cryptocurrencies to eco-friendly tokens, these six cryptocurrencies are turning heads. That’s why you should keep an eye on them. 1. Wall Street Baby $ call He’s making a splash…
-
Institutional Inflows to Bitcoin ETFs Show Promising Indicator, Says Coinbase Report
•
Coinbase has Reported Updated 13-F filings for Q2 2024 indicate a significant increase in institutional inflows into U.S. Bitcoin ETFs, which the firm sees as a “promising indicator” for the Bitcoin market. The 13-F filings, released on August 14, reveal that institutional ownership of these ETFs grew from 21.4% to…
-
Institutional Inflows to Bitcoin ETFs Show Promising Indicator, Says Coinbase Report
•
Coinbase has Reported Updated 13-F filings for Q2 2024 indicate a significant increase in institutional inflows into U.S. Bitcoin ETFs, which the firm sees as a “promising indicator” for the Bitcoin market. The 13-F filings, released on August 14, reveal that institutional ownership of these ETFs grew from 21.4% to…
-
Bitcoin’s Bullish Future: Why BTC’s Long-term View Still Looks Promising
•
after BitcoinFollowing the recent recovery of Bitcoin price from a significant drop last week due to the broader market downturn, investors and traders have been speculating on the crypto asset’s short- and long-term performance. However, crypto analyst and trader Mags, who delved into the current price recovery, revealed that Bitcoin…
-
From Promising Start To Slow Adoption
•
A Reserve Bank of India (RBI) stamp is pictured on a gate outside the Reserve Bank of India headquarters in Mumbai, India, February 2, 2016. REUTERS/Danish Siddiqui/File Photo India’s entry into the world of central bank digital currencies (CBDCs) has been a closely watched endeavor, with the launch of the…
-
BioAtla reports promising data in cancer drug trials By Investing.com
•
BioAtla, a biotechnology company, has announced its first-quarter financial results and provided a business update, highlighting positive data from ongoing clinical trials and the potential for strategic partnerships. The company showcased encouraging results from its CAB-ROR2-ADC drug in treating head and neck cancer and is preparing for FDA guidance on…